Proton Therapy for Cancer in India
India has 3 operational proton therapy centres: Apollo Proton Cancer Centre (Chennai), Manipal Hospital (Bangalore), and HCG Oncology. Proton therapy delivers precise radiation with minimal damage to surrounding healthy tissue — ideal for paediatric cancers, brain tumours, and head & neck cancers.
Check Your Eligibility — Free
Send your reports. Our specialists will review and confirm whether Proton Therapy is right for your case.
📋 Get Free Assessment| Cost Comparison | India | USA |
|---|---|---|
| Proton Therapy | $15,000–$28,000 | $60,000–$120,000 |
| Savings | 60–80% less than USA | |
Conditions Treated with Proton Therapy
- Paediatric brain tumours (medulloblastoma, ependymoma)
- Head and neck cancers (complex anatomy)
- Prostate cancer (alternative to IMRT/brachytherapy)
- Skull base and spinal tumours
- Liver cancer (small HCC tumours)
- Ocular melanoma
- Re-irradiation cases (prior photon RT)
How Proton Therapy Works (Step by Step)
- Oncologist referral and proton eligibility assessment
- Dosimetric planning (comparison with photon RT)
- Immobilisation and simulation (custom mask/cradle)
- Pencil beam scanning (PBS) treatment delivery
- Daily fractions over 4–7 weeks (or 1–5 for SBPT)
- Weekly on-treatment review
Benefits of Proton Therapy in India
- Bragg peak effect — dose deposited precisely at tumour depth
- No exit dose — reduces second malignancy risk in paediatric patients
- Spares critical structures (optic chiasm, brainstem, spinal cord, cochlea)
- 60–75% reduction in low-dose radiation to healthy tissue vs IMRT
Best Hospitals for Proton Therapy in India
- Apollo Proton Cancer Centre, Chennai (850+ protons/year)
- Manipal Hospital, Bangalore
- HCG Oncology, multiple centres
Frequently Asked Questions
Q: Is proton therapy available in India?
A: Yes. India has 3 proton therapy centres. Apollo Proton Cancer Centre in Chennai is the largest in South Asia, treating over 850 patients annually. Proton therapy in India costs $15,000–$28,000 vs $60,000–$120,000 in the USA.